Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01895283
Other study ID # H-2-2013-066
Secondary ID
Status Completed
Phase N/A
First received July 3, 2013
Last updated April 4, 2016
Start date September 2013
Est. completion date January 2015

Study information

Verified date April 2016
Source Rigshospitalet, Denmark
Contact n/a
Is FDA regulated No
Health authority Denmark: Danish Dataprotection AgencyDenmark: The Regional Committee on Biomedical Research Ethics
Study type Interventional

Clinical Trial Summary

Muscular dystrophy is a group of disorders that are characterized by progressive muscle weakening and loss of muscle mass, caused by defects in muscle proteins. Muscular dystrophy is almost always inherited disorders, and so far, no curative treatments exist.

Previous studies have shown that endurance training significantly improves fitness and self-assessed muscle function in a variety of muscular dystrophies. In this study, we wish to investigate whether patients with Bethlem myopathy (a specific form of muscular dystrophy) also benefit from endurance training.

The study consists of two test days, a 10-week training period and five blood tests.

Patients will be required to train, three times per week, for 10 weeks, on a bike ergometer with a specific training intensity, under pulse rate monitoring.

The training period will be flanked by two test days, where we will determine, and compare the patients' muscle strength and fitness level, from before to after the training program. The patients conditioning level will be determined from a 15 minute cycle ergometer test and patients will undergo three functional tests to determine their functional muscle strength.

We will as a safety measure analyze blood tests before, during and after the training program for the muscle enzyme creatine kinase (an indicator of muscle damage) and through adverse effects as reported by patients during weekly telephone-consultations with the Principal investigator.

We anticipate, that Bethlem myopathy patients will have a similar rise in fitness level and functional muscle strength, as that seen in patients with other forms of muscular dystrophy, who undertake a similar training program.


Recruitment information / eligibility

Status Completed
Enrollment 7
Est. completion date January 2015
Est. primary completion date December 2014
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 16 Years to 90 Years
Eligibility Inclusion Criteria:

- Patients with Bethlem myopathy

Exclusion Criteria:

- Patients with disorders that would confound the interpretation of the effect from training (cardiomyopathy, pregnant women, etc.)

- Patients who are deemed mentally unfit for cooperation with the training program

Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention


Intervention

Behavioral:
Moderate-intensity training
Training at 70% of VO2max, for 1/2 hour, three times weekly, for 10 weeks, on a bike ergometer.

Locations

Country Name City State
Denmark Rigshospitalet, Neuromuscular Research Unit, section 3342 Copenhagen

Sponsors (1)

Lead Sponsor Collaborator
Rigshospitalet, Denmark

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Other Safety The safety of undertaking a 10-week training program will be determined by analyzing reports of adverse effects faced during the training program, and by interpretation of Creatine Kinase levels measured before, during and after the training program. During a 10 week training program Yes
Primary Maximal oxygen uptake (VO2max) VO2max will be determined during an incremental bike test to exhaustion. VO2max is a physiological measure of physical fitness. VO2max relies on a persons ability to supply and consume oxygen ("energy") in muscle tissue. after 10 week bike ergometer training program No
Secondary Functional muscle strength Functional muscle strength will be determined by performance in three functional tests: a five-repetition-sit-to-stand-test, a 6 minute walk test and a 14 step stair test. After completion of a 10 week training program No
Secondary Muscle strength determined by dynamometry After completion of a 10 week training program No
Secondary Self-assessed improvements in muscle function After completion of a 10 week training program No
Secondary Self-assessed improvements in incidence of problems that are related to inactivity (in patients who are confined to a wheel-chair) After a 10 week training program No
See also
  Status Clinical Trial Phase
Recruiting NCT03693898 - MR in Patients With Collagen VI Related Myopathies N/A
Completed NCT01438788 - Low Protein Diet in Patients With Collagen VI Related Myopathies Phase 2
Recruiting NCT04020159 - Global Registry for COL6-related Dystrophies